Immune Tolerance Network Proposal Guidelines

About this program

The Immune Tolerance Network (ITN) invites proposals from academic, industry, and government scientists for novel clinical trials in allergy and asthma, autoimmune diseases, and kidney or liver transplantation. It also supports development of immune-tolerance assays, surrogate biomarkers, and mechanistic studies using ITN resources in existing or externally funded clinical trials; non-human and preclinical studies are not eligible. Applicants begin with an approximately five-page Concept Proposal, followed by a Full Application if invited, with submissions accepted year-round and reviewed several times annually.